XCUR — Exicure Inc
NASDAQ · Healthcare · Biotechnology
$1.28
-$0.02 (-1.62%)
Exicure Inc (XCUR) is a biotechnology company listed on NASDAQ. It is led by Jungsoo Kim, based in 400 Seaport Court, Redwood City, CA, United States, 94063, with about 2 employees. Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Latest reported XCUR revenue for 2025-09-30 was $0. Net income was -$2.4M. XCUR currently screens at market cap $13.7M.
Use this XCUR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XCUR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XCUR SEC filings page. Lician reads the product cache first so this HTML stays unique to Exicure Inc even when a live quote feed is slow.
About Exicure Inc
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
XCUR Key Statistics
Market Cap
$13.70M
Volume
18,306
Previous Close
$1.15
Day Range
$1.13 – $1.23
P/B Ratio
6.53
EPS
-$4.75
Revenue
$500.00K
Net Income
-$9.70M
Gross Profit
$0.00
Free Cash Flow
$0.00
Profit Margin
-1940.2%
Employees
2
XCUR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $500.00K | $0.00 | $28.83M | -$483.00K |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$9.70M | -$16.91M | -$2.58M | -$64.10M |
| EPS (Diluted) | -$4.75 | -$10.55 | -$0.56 | -$21.70 |
Total Assets
$15.06M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$0.00
Operating Cash Flow
-$2.91M
Free Cash Flow
$0.00
Exicure Inc Company Information
- CEO, President & Director
- Jungsoo Kim
- Headquarters
- 400 Seaport Court, Redwood City, CA, United States, 94063
- Website
- www.exicuretx.com
- Phone
- 847 673 1700
- IPO / Founded
- 2018-05-22
- Sector
- Healthcare
- Industry
- Biotechnology